Targeting Parkinson's Disease 2011
June 8 - 9, 2011
费城 PA , 美国
DISEASE MODIFICATION TARGETS
Translational Control of alpha-Synuclein: New Treatment for Parkinson’s Disease
Targeting Nuclear Hormone Receptors to Treat Neurodegenerative Disease
MOUSE MODELS
Mitopark Mice: A Model of Progressive Dopamine Depletion and Parkinsonism
IMAGING
Animal Model of Presymptomatic Parkinson’s Diseases
BIOMARKERS
Is Modulating Synuclein Phosphorylation a Potential Disease Modifying Approach for Parkinson’s Disease?
TARGETING SYMPTOMS OF PARKINSON’S
Novel mGluR4 Positive Allosteric Modulators in Parkinson’s Disease
Translational Control of alpha-Synuclein: New Treatment for Parkinson’s Disease
Targeting Nuclear Hormone Receptors to Treat Neurodegenerative Disease
MOUSE MODELS
Mitopark Mice: A Model of Progressive Dopamine Depletion and Parkinsonism
IMAGING
Animal Model of Presymptomatic Parkinson’s Diseases
BIOMARKERS
Is Modulating Synuclein Phosphorylation a Potential Disease Modifying Approach for Parkinson’s Disease?
TARGETING SYMPTOMS OF PARKINSON’S
Novel mGluR4 Positive Allosteric Modulators in Parkinson’s Disease
相关活动
Targeting Parkinson's Disease June 4 - 6, 2013
Targeting Parkinson's Disease 4 June, 2012
Targeting Parkinson's Disease June 8 - 9, 2011
